Olivier Séror

5.4k total citations · 1 hit paper
102 papers, 2.7k citations indexed

About

Olivier Séror is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Olivier Séror has authored 102 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hepatology, 50 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Olivier Séror's work include Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Liver Disease Diagnosis and Treatment (44 papers) and Liver Disease and Transplantation (19 papers). Olivier Séror is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Liver Disease Diagnosis and Treatment (44 papers) and Liver Disease and Transplantation (19 papers). Olivier Séror collaborates with scholars based in France, Italy and Switzerland. Olivier Séror's co-authors include Nathalie Ganne‐Carrié, Pierre Nahon, G. Nkontchou, Michel Beaugrand, Jean‐Charles Nault, N. Sellier, Olivier Sutter, Jean–Claude Trinchet, Emmanuelle Coderc and Jean Claude Trinchet and has published in prestigious journals such as Hepatology, Gut and Scientific Reports.

In The Last Decade

Olivier Séror

93 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations

2017 293 citations Jean‐Charles Nault, Olivier Sutter et al. Journal of Hepatology profile →

Peers

Olivier Séror

HEPAT

EPIDE

SURGE

RNMI

Hobyung Chung Japan

Tatsuo Inoue Japan

Ryota Masuzaki Japan

Shinpei Sato Japan

Yasunori Minami Japan

Tadashi Goto Japan

Sylvain Terraz Switzerland

Sergio Lazzaroni Italy

Atsuo Inoue Japan

Satoru Hagiwara Japan

Hobyung Chung Japan

Olivier Séror

2.7k ×1.5

HEPAT

2.0k ×1.7

EPIDE

665 ×1.1

SURGE

306 ×0.8

411 ×1.1

RNMI

Citations per year, relative to Olivier Séror Olivier Séror (= 1×) peers Hobyung Chung

Countries citing papers authored by Olivier Séror

Since Specialization

Citations

This map shows the geographic impact of Olivier Séror's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Séror with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Séror more than expected).

Fields of papers citing papers by Olivier Séror

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Séror. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Séror. The network helps show where Olivier Séror may publish in the future.

Co-authorship network of co-authors of Olivier Séror

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Séror. A scholar is included among the top collaborators of Olivier Séror based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Séror. Olivier Séror is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paisant, Anita, Agnès Rode, Riccardo Sartoris, et al.. (2025). Improving risk stratification and detection of early HCC using ultrasound-based deep learning models. JHEP Reports. 7(10). 101510–101510.

Blaise, Lorraine, Marianne Ziol, Claudia Campani, et al.. (2025). Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma. JHEP Reports. 7(9). 101430–101430. 1 indexed citations

Campani, Claudia, Sandrine Imbeaud, Gabrielle Couchy, et al.. (2024). Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 73(11). 1870–1882. 21 indexed citations

Cannella, Roberto, Marco Dioguardi Burgio, Riccardo Sartoris, et al.. (2024). Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma. Radiology. 310(2). e231160–e231160. 13 indexed citations

Campani, Claudia, Manon Allaire, Philippe Sultanik, et al.. (2023). Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab. Hepatology. 79(1). 49–60. 14 indexed citations

Laurent‐Puig, Pierre, Marianne Ziol, Nathalie Ganne‐Carrié, et al.. (2023). Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab. Journal of Hepatology. 79(6). 1450–1458. 29 indexed citations

Campani, Claudia, Sandrine Imbeaud, Marianne Ziol, et al.. (2023). Dynamic evolution of circulating tumor DNA in patients with hepatocellular carcinoma across tumor stages and treatments. Digestive and Liver Disease. 55. S213–S214. 1 indexed citations

Sutton, Angéla, Lorraine Blaise, Olivier Séror, et al.. (2022). Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 9. 1369–1383. 2 indexed citations

Sutter, Olivier, et al.. (2022). Automated needle localisation for electric field computation during an electroporation ablation. HAL (Le Centre pour la Communication Scientifique Directe). 1279–1284. 1 indexed citations

10.

Bérégi, Jean-Paul, Olivier Séror, Jean-Jacques Wenger, et al.. (2022). Early results of a French care-related adverse events database in radiology. Diagnostic and Interventional Imaging. 103(4). 201–207. 2 indexed citations

11.

Nahon, Pierre, Christophe Aubé, Lucile Moga, et al.. (2021). Non-invasive diagnosis and follow-up of primary malignant liver tumours. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101766–101766. 2 indexed citations

12.

Senneville, Baudouin Denis de, et al.. (2019). Numerical workflow of irreversible electroporation for deep-seated tumor. Physics in Medicine and Biology. 64(5). 55016–55016. 23 indexed citations

13.

Gelu‐Siméon, Moana, M. Lewin, Maria A. Ostos, et al.. (2018). Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver International. 39(1). 136–146. 11 indexed citations

14.

Allaire, Manon, Richard Layese, Erwan Guyot, et al.. (2018). Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Digestive and Liver Disease. 51(1). 86–94. 14 indexed citations

15.

Chalaye, Julia, Charlotte Costentin, Alain Luciani, et al.. (2018). Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma. Journal of Hepatology. 69(2). 336–344. 40 indexed citations

16.

Nault, Jean‐Charles, Erwan Guyot, Christelle Laguillier, et al.. (2013). Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis. Cancer Epidemiology Biomarkers & Prevention. 22(8). 1343–1352. 65 indexed citations

17.

Nahon, Pierre, Roland Amathieu, Mohamed N. Triba, et al.. (2012). Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis. Clinical Cancer Research. 18(24). 6714–6722. 64 indexed citations

18.

Séror, Olivier. (2011). Radiofréquences et autres techniques d’ablation hépatique percutanée : ce qu’il faut savoir en 2011. Journal de Radiologie. 92(9). 763–773.

19.

Nkontchou, G., Mounir Aout, Nathalie Ganne‐Carrié, et al.. (2009). Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis #. Hepatology. 50(5). 1475–1483. 355 indexed citations

20.

Séror, Olivier, G. Nkontchou, Myint Tin Tin Htar, et al.. (2008). Radiofrequency Ablation with Internally Cooled versus Perfused Electrodes for the Treatment of Small Hepatocellular Carcinoma in Patients with Cirrhosis. Journal of Vascular and Interventional Radiology. 19(5). 718–724. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact